Authors


Brendan Girschek, MD, FRCSC, FACS

Latest:

Satellite clinics and other strategies to enhance rural ophthalmology 

Proactive communication and leveraging advanced, yet reliable, technologies  to maximize efficiency are essential pillars of success.


Marta Stevanovic, MD, MSc

Latest:

The future of retina care

Retina is a rapidly advancing field with promising research, technology, and treatment areas. Two stand out as particularly exciting.


Winston Posvar, OD, MS, FAAO

Latest:

Using virtual reality mobility testing as a standardized clinical end point in inherited retinal disorders

The use of VR mazes hold an intrinsic advantage compared with physical mazes in the ability to control conditions and test various patterns with reliability, participant safety, and repeatability.


Robert P. Finger, MD, PhD

Latest:

Investigating the quality of real-world evidence in retinal disease

Real-world evidence is growing in importance as a source of information that can help support clinical decision-making when evaluated properly.


Andrew Pucker, OD, MS, PhD, FAAO

Latest:

Using virtual reality mobility testing as a standardized clinical end point in inherited retinal disorders

The use of VR mazes hold an intrinsic advantage compared with physical mazes in the ability to control conditions and test various patterns with reliability, participant safety, and repeatability.


Mark R. Barakat, MD

Latest:

Precision medicine in diabetic macular edema: Expert consensus on the efficacy and safety of the 0.19-mg fluocinolone acetonide implant

Results from expert surveys provide snapshots of our understanding of DME and shed light on where the 0.19-mg FAc implant stands in the current standard of care.


Mark Michels, MD

Latest:

Dexamethasone rebuttal: Who should perform intravitreal injections?

In response to a previously published article, three ophthalmologists present their views on intravitreal pharmacotherapy injections.



Grace Koennecke

Latest:

The implications of real-world data integration in health care and ophthalmology

Sujay Jadhav, CEO of Verana Health, a digital health company dedicated to revolutionizing patient care and clinical research through real-world data (RWD), provides an overview of new FDA guidance.



Ashvini Reddy, MD

Latest:

Sustained drug delivery in ophthalmology

Current options, challenges in developing novel therapies.


Paul Hahn, MD, PhD

Latest:

Pegcetacoplan vs Avacincaptad Pegol in Patients With Geographic Atrophy

A retina specialist shares his presentation from the 2023 ASRS Annual Meeting, which describes a study comparing the efficacy of 2 FDA-approved treatments for geographic atrophy based on an anchored matching-adjusted indirect comparison of phase 3 trial findings.



Kassi Jackson

Latest:

FDA issues CRL for aflibercept 8 mg from Regeneron Pharmaceuticals

The company announced the Complete Letter Response from the FDA for the Biologics License Application for aflibercept 8 mg is “solely due to an ongoing review of inspection findings at a third-party filler.”


Varun Chaudhary, MD, FRCS(C)

Latest:

Key Retreatment Decisions in the Clinical Trials for Faricimab in nAMD

Dr Varun Chaudhary presents the retreatment decisions during the treat-and-extend phase of the TENAYA and LUCERNE clinical trials in neovascular AMD, focusing on the percentage of patients who maintained, extended, or reduced their treatment interval based on visual and anatomic criteria.


Roche

Latest:

UNCOVERING HIDDEN PREDATORS IN DISEASE

This article is produced by Roche for healthcare professionals and is not intended to provide medical advice and/or treatment guidance. This website is not country-specific and therefore may contain information which is not applicable to your country.


Theodore Leng, MD, MS

Latest:

Natural language processing helps ophthalmologists access data, improves data curation

Knowledge of tools used in data interpretation helps clinicians trust accuracy of findings.


Sheri Rowen, MD, FACS

Latest:

Latest tech trends to benefit patients with AMD

Technology brings new tools to those with low vision caused by AMD


Rahul N. Khurana, MD

Latest:

Overcoming the wet AMD treatment gap

A key distinction between patients seen in the clinic vs those enrolled in clinical trials has to do with characteristics dictated by the trial’s inclusion/exclusion criteria.


James P. Dunn, MD

Latest:

Successful ocular surgery in patients with chronic uveitis

While operating on a patient with chronic uveitis presents some challenges, there are a few pearls that may increase success.


Judy Kim, MD

Latest:

Promoting Treatment Adherence in nAMD and DME

Experts conclude the series with the hope that longer-acting agents will lead to better real-world outcomes for patients, mirroring clinical trial results and potentially preventing vision loss, especially in countries with limited access to healthcare.


Jaclyn L. Kovach, MD

Latest:

Is complement therapy the path forward for geographic atrophy?

Clinical benefit of complement inhibition has been demonstrated in clinical trials, but there are possible consequences to consider.


Emily Kaiser

Latest:

US FDA issues approval for two aflibercept biosimilars

The agency approved Yesafili (Biocon Biologics) and Opuviz (Samsung Bioepis, Biogen) as biosimilars to Eylea (Regeneron Pharmaceuticals).


Marc D. de Smet, MD, PhD

Latest:

Adapting medical retina service in COVID-19 era requires careful approach

Minimizing clinic visits, maximizing use of imaging modalities are key



Marlissa Miller

Latest:

ABVC BioPharma announces approved plan for pilot Good Manufacturing Practice (GMP) facility to produce Vitargus

The plan is intended to upgrade Vitagrus’ manufacturing process so that it can ultimately handle the global market supply.



Veena Raiji, MD, MPH

Latest:

Successful treatment of bilateral diffuse Uveal melanocytic proliueration with plasmapheresis

Nonetheless,BDUMP remains a rare condition with fewer than 60 cases documented in literature.


Christopher Or, MD

Latest:

Ultra-widefield imaging: A critical step in uveitis diagnosis and management

A multifaceted evaluation that includes ultra-widefield imaging can reveal new information and influence treatment decisions.


Sally Justus, BA

Latest:

Q&A: The increasing potential of ERG in diagnosing a wide range of eye conditions

Easier, more accessible functional studies have been made possible

© 2024 MJH Life Sciences

All rights reserved.